Asymmetrical dimethylarginine (ADMA) and risk of acute coronary events - Does statin treatment influence plasma ADMA levels?

Author: Valkonen V.-P.   Laakso J.   Paiva H.   Lehtimaki T.   Lakka T.A.   Isomustajarvi M.   Ruokonen I.   Salonen J.T.   Laaksonen R.  

Publisher: Elsevier

ISSN: 1567-5688

Source: Atherosclerosis, Supplements, Vol.4, Iss.4, 2003-12, pp. : 19-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content